Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after ...
Georgetown University psychologist Andrea Bonior told Fox News Digital she has seen an uptick in patients, many of whom are ...
BACKGROUND: Limited evidence exists on the prognostic role of continuing medical therapy in patients with heart failure (HF) ...
An indigenously developed CAR T-cell gene therapy has achieved a 73% response rate for certain blood cancers in India. The ...
The difficulty of securing insurance coverage can impede the therapy process. Armed with advice and templates, a nonprofit is helping patients and providers get what they're due.
The Punch on MSN34m
Gene therapy delivers alternative sickle cell cure in USSebastien Beauzile from Laurelton, Long Island, has become the first person in New York State to be cured of sickle cell ...
Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...
In a real-world study, researchers found this data by comparing treatment patterns, healthcare resource utilization, and ...
In a late-stage trial of patients with multiple types of blood cancer, Orca Bio’s allogeneic T-cell immunotherapy doubled the ...
NY resident Sebastien Beauzile was treated with a pioneering new gene therapy approach called Lyfgenia, curing his sickle ...
The study looked at patients with leukaemia, which occurs in bone marrow, and lymphoma, which affects the lymphatic system.
AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback